Please join us for a day-long Dean's Symposium featuring leaders in immunology from around the country for presentations, discussion, and networking.
Harkness Auditorium
333 Cedar Street, New Haven, CT
8:30am - 5:00pm
Thank you to our event sponsors: Bristol-Myers Squibb, Merck, and Pfizer.
AGENDA
8:30 - 9:00 Registration and Breakfast
Opening Remarks
9:00 - 9:15
Charles S. Fuchs, MD, MPH, Director, Yale Cancer Center; Physician-in-Chief, Smilow Cancer Hospital
David Schatz, PhD, Chair, Department of Immunobiology
Roy S. Herbst, MD, PhD, Chief of Medical Oncology; Associate Director for Translational Research; Ensign Professor of Medicine
Marcus Bosenberg, MD, PhD, Professor of Dermatology, Pathology, and Immunobiology, Co-Leader, Genetics, Genomics and Epigenetics Research Program; Interim Director, Yale Cancer for Immuno-Oncology
Visualizing Tumor Immunity and Response
9:15 - 10:15
Anna Wu, PhD, Professor and Chair, Department of Molecular Imaging and Therapy, Beckman Research Institute, City of Hope
10:15 - 10:45
David Rimm, MD, PhD, Professor of Pathology and of Medicine, Yale School of Medicine
10:45 - 11:00 Coffee Break
Taming the Tumor Microenvironment Ecosystem
11:00 - 12:00
Greg M. Delgoffe, PhD, Assistant Professor, Immunology, University of Pittsburgh
12:00 - 1:00
Drew Mark Pardoll, MD, PhD, Director, Bloomberg-Kimmel Institute for Cancer Immunotherapy, Abeloff Professor of Oncology, Johns Hopkins University
1:00 - 2:00 Lunch
Improving Therapeutic Success
2:00 - 3:00
Cornelia Liu Trimble, MD, Professor of Gynecology and Obstetrics, Oncology and Pathology, Johns Hopkins School of Medicine
3:00 - 3:30
Katerina Politi, PhD, Associate Professor of Pathology, Yale Cancer Center
3:30 - 3:45 Coffee Break
Developing Novel and Cell-Based Therapies
3:45 - 4:15
Lieping Chen, MD, PhD, United Technologies Corporation Professor in Cancer Research and Professor of Immunobiology, Dermatology and Medicine (Medical Oncology), Yale School of Medicine
4:15 - 4:45
Mario Sznol, MD, Professor of Medicine (Medical Oncology), Yale Cancer Center
Closing Remarks
4:45 - 4:50
Roy S. Herbst, MD, PhD, Chief of Medical Oncology; Associate Director for Translational Research; Ensign Professor of Medicine; Interim Director of the Yale Center of Immuno-Oncology
Marcus Bosenberg, MD, PhD, Professor of Dermatology, Pathology, and Immunobiology, Co-Leader, Genetics, Genomics and Epigenetics Research Program; Interim Director, Yale Cancer for Immuno-Oncology
The Yale School of Medicine designates this live activity for a maximum of 6.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. The Yale School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.